000 | 01886 a2200529 4500 | ||
---|---|---|---|
005 | 20250517060806.0 | ||
264 | 0 | _c20161018 | |
008 | 201610s 0 0 eng d | ||
022 | _a1538-8514 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-15-0063 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCesca, Marta | |
245 | 0 | 0 |
_aBevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cJan 2016 |
||
300 |
_a125-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 | _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aMorosi, Lavinia | |
700 | 1 | _aBerndt, Alexander | |
700 | 1 | _aFuso Nerini, Ilaria | |
700 | 1 | _aFrapolli, Roberta | |
700 | 1 | _aRichter, Petra | |
700 | 1 | _aDecio, Alessandra | |
700 | 1 | _aDirsch, Olaf | |
700 | 1 | _aMicotti, Edoardo | |
700 | 1 | _aGiordano, Silvia | |
700 | 1 | _aD'Incalci, Maurizio | |
700 | 1 | _aDavoli, Enrico | |
700 | 1 | _aZucchetti, Massimo | |
700 | 1 | _aGiavazzi, Raffaella | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 15 _gno. 1 _gp. 125-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-15-0063 _zAvailable from publisher's website |
999 |
_c25380994 _d25380994 |